Advertisement

Topics

Non-Interventional Post Marketing Surveillance Study To Evaluate The Safety And Efficacy Of Vfend® IV

2014-07-23 21:10:02 | BioPortfolio

Summary

This is non-interventional study of voriconazole IV formulation in clinical use, which was mandated by the Korean government agency following the approval of Vfend in the Republic of Korea.

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Conditions

Candidemia

Intervention

voriconazole IV

Status

Completed

Source

Pfizer

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-07-23T21:10:02-0400

Clinical Trials [88 Associated Clinical Trials listed on BioPortfolio]

A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.

This is a study to investigate the safety and efficacy of voriconazole for the treatment of candidemia in critically ill non-neutropenic patients

This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis

The primary objective is to estimate global response rate. Clinical, microbiological and global response rates and its 95% confidence intervals will be computed. No hypotheses will be test...

Isavuconazole in the Treatment of Candidemia and Other Invasive Candida Infections

The purpose of the study is to compare the safety and efficacy of Isavuconazole versus caspofungin followed by voriconazole in the treatment of candidemia and other invasive Candida infect...

Non-Interventional Post Marketing Surveillance Study To Evaluate The Safety And Efficacy Of Vfend® Tablet In Korea

This is a non-interventional study of voriconazole tablet in Korea which is mandated by the Korean government agency.

Influence of Drug-drug Interactions on the Pharmacokinetics (PK) of Voriconazole

To evaluate the drug-drug interaction between rifampicin and voriconazole according to CYP2C19 genotype quantitatively following a single oral administration of 200 mg voriconazole

PubMed Articles [77 Associated PubMed Articles listed on BioPortfolio]

Isavuconazole versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.

Isavuconazole was compared to caspofungin followed by oral voriconazole in a phase 3, randomized, double-blind, multinational clinical trial (ACTIVE; NCT00413218) for primary treatment of patients wit...

A Tale of Two Healthcare-Associated Infections: Clostridium difficile Coinfection Among Patients with Candidemia.

Candidemia and Clostridium difficile infection (CDI) are important healthcare-associated infections that share certain risk factors. We sought to describe candidemia-CDI coinfection using population-b...

Pediatric Candidemia Epidemiology and Morbidities: A Nationwide Cohort.

Candidemia is the most frequent pediatric fungal infection, but incompletely elucidated in population-based settings. We performed a nationwide cohort study including all pediatric patients with candi...

Prediction of the effect of voriconazole on the pharmacokinetics of non-steroidal anti-inflammatory drugs.

To evaluate the impact of voriconazole on the pharmacokinetics of Non-steroidal anti-inflammatory drugs (NSAIDs). Pharmacokinetic and physiochemical properties of voriconazole and NSAIDs are applied t...

Clinical characteristics and predictors of mortality in patients with candidemia: a six-year retrospective study.

Although candidemia has been reported globally, little is known about the differences in candidemia episodes between ICU and surgical wards or the correlation between serum biomarkers and mortality fr...

Medical and Biotech [MESH] Definitions

A triazole antifungal agent that specifically inhibits STEROL 14-ALPHA-DEMETHYLASE and CYTOCHROME P-450 CYP3A.

A form of invasive candidiasis where species of CANDIDA are present in the blood.

An important nosocomial fungal infection with species of the genus CANDIDA, most frequently CANDIDA ALBICANS. Invasive candidiasis occurs when candidiasis goes beyond a superficial infection and manifests as CANDIDEMIA, deep tissue infection, or disseminated disease with deep organ involvement.

More From BioPortfolio on "Non-Interventional Post Marketing Surveillance Study To Evaluate The Safety And Efficacy Of Vfend® IV"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Searches Linking to this Trial